Not the norm of how BP operate. They usually only do license deal with companies close to end of Ph3 as they are close to commercialisation. Why would they want to spend a lot of money funding another company's Ph3 clinical trial???
Media Thread, page-12304
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
0.001(1.00%) |
Mkt cap ! $367.4M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.1¢ | 4.9¢ | $284.7K | 5.691M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 603643 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 934627 | 18 |
View Market Depth
| Last trade - 13.01pm 09/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |